8-K: FOXO Technologies Authorizes New Series A Preferred Stock and Addresses Legal Liabilities

FOXO Technologies has authorized a new series of preferred stock and is taking steps to resolve outstanding legal issues, including a significant debt settlement.

Summary

• FOXO Technologies has filed an amendment to its Certificate of Incorporation to authorize 35,000 shares of Series A Cumulative Convertible Redeemable Preferred Stock.
• The Series A Preferred Stock has a par value of $0.0001 per share and includes specific rights, preferences, and limitations.
• Holders of Series A Preferred Stock are entitled to cumulative cash dividends at a rate of 5% per annum on a stated value of $1,000 per share, payable quarterly starting March 15, 2025.
• The Series A Preferred Stock has a liquidation preference equal to the stated value plus any accrued and unpaid dividends before any distribution to common stockholders.
• Each share of Series A Preferred Stock is convertible into common stock at a conversion price based on the higher of $0.01 or 90% of the average VWAP of the five trading days prior to conversion.
• The company is also addressing legal proceedings, including a judgment of $821,670.40 from Illumina, Inc., which they hope to settle by exchanging equity.
• Additionally, the company has reached an agreement with over 50.01% of holders of Senior PIK Notes to exchange the notes into Series B Preferred Stock, which will resolve legal actions for $378,625 and $757,250.
• The total value of the Senior PIK Notes, including accrued interest, was $4,706,628.92 as of June 30, 2024, and will be cancelled upon the exchange.
• The Series B Preferred Stock will not be convertible into Class A Common Stock until one year after issuance.

Sentiment

Score: 4

Explanation: The document reveals significant financial challenges and legal issues, although the company is taking steps to address them. The sentiment is negative due to the existing liabilities and debt, but there are some positive aspects in the restructuring efforts.

Positives

• The authorization of Series A Preferred Stock provides the company with a new financing tool.
• The agreement to exchange Senior PIK Notes for Series B Preferred Stock will resolve outstanding legal actions and reduce debt.
• The company is actively working to settle the debt with Illumina, Inc. through equity exchange.
• The conversion feature of the Series A Preferred Stock could be attractive to investors.

Negatives

• The company is facing legal actions for non-payment of services and debt.
• The judgment against the company by Illumina, Inc. for $821,670.40 is a significant liability.
• The company had a total of $4,706,628.92 in Senior PIK Notes debt and accrued interest as of June 30, 2024.
• The Series B Preferred Stock cannot be converted into common stock for one year, which may limit its appeal to some investors.

Risks

• The company may not be successful in settling the debt with Illumina, Inc. through equity exchange.
• The company's financial position is under pressure due to outstanding legal liabilities.
• The conversion of preferred stock into common stock could dilute existing shareholders.
• The company's ability to meet its dividend obligations on the Series A Preferred Stock is dependent on its financial performance.

Future Outlook

The company intends to settle the Illumina debt through equity exchange and resolve the Senior PIK Notes legal actions by converting the notes into Series B Preferred Stock. The company will seek stockholder approval for the conversion of the Series B Preferred Stock into Class A Common Stock.

Management Comments

• The Company is in discussions with Illumina to reach a settlement of this liability and hopes to secure a settlement agreement to satisfy the debt by exchanging it for equity in the Company.
• The Company believes that this amendment will lead to settlement of the legal actions described above under the subheading Senior PIK Notes.

Industry Context

The authorization of preferred stock and debt restructuring are common strategies for companies facing financial challenges. The legal issues and debt restructuring highlight the company's need to improve its financial stability and operational performance.

Comparison to Industry Standards

• Many biotech and technology companies use preferred stock to raise capital, especially when facing financial difficulties.
• The 5% dividend rate on the Series A Preferred Stock is within the typical range for preferred stock offerings.
• The conversion feature of the Series A Preferred Stock is a common incentive for investors in such offerings.
• The debt restructuring through the exchange of Senior PIK Notes for preferred stock is a common method for companies to reduce debt and resolve legal issues.
• Companies like Sorrento Therapeutics and Cassava Sciences have also used similar strategies to manage debt and raise capital.

Corporate Governance

Legal Proceedings

• Illumina, Inc. secured a judgment for $821,670.40 against the Company for non-payment of services.
• Two holders of Senior PIK Notes initiated legal action against the Company for non-payment of amounts due under the Senior PIK Notes for $378,625 and $757,250, respectively.

Stakeholder Impact

• Shareholders may experience dilution if the preferred stock is converted into common stock.
• Creditors, specifically the holders of Senior PIK Notes, will have their debt converted into equity.
• The company's ability to pay dividends on the Series A Preferred Stock will impact investors holding this stock.
• The resolution of legal issues will improve the company's financial stability.

Next Steps

• The company will seek to finalize a settlement agreement with Illumina, Inc.
• The company will complete the exchange of Senior PIK Notes for Series B Preferred Stock.
• The company will seek stockholder approval for the conversion of Series B Preferred Stock into Class A Common Stock.

Key Dates

Keywords

Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Convertible Stock, Legal Proceedings, Debt Settlement, Senior PIK Notes, Illumina, Equity Exchange, Dividends